Rare Diseases Working Group Should Address CLIA Lab Participation – SACGT
This article was originally published in The Gray Sheet
Executive Summary
The Rare Diseases Working Group of the HHS Secretary's Advisory Committee on Genetic Testing should look at ways to shift testing for rare diseases from research labs to CLIA-certified clinical labs, the committee concluded
You may also be interested in...
DePuy Weighs HDE Costs; FDA Stresses Data Options Over Statutory Limits
The Center for Devices & Radiological Health is encouraging greater use of humanitarian device exemptions by inviting manufacturers to submit alternative forms of data to support submissions
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.